Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
Mirja Rotinen, Sungyong You, Julie Yang, et al.
Nature Medicine (2018) Vol. 24, Iss. 12, pp. 1887-1898
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

Prostate cancer
Richard J. Rebello, Christoph Oing, Karen E. Knudsen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Closed Access | Times Cited: 742
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee, Jens Rauch, Walter Kölch
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1102-1102
Open Access | Times Cited: 637
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Himisha Beltran, Andrew M. Hruszkewycz, Howard I. Scher, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 23, pp. 6916-6924
Open Access | Times Cited: 297
Clinical and Biological Features of Neuroendocrine Prostate Cancer
Yasutaka Yamada, Himisha Beltran
Current Oncology Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 195
Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma
Lindsay M. LaFave, Vinay K. Kartha, Sai Ma, et al.
Cancer Cell (2020) Vol. 38, Iss. 2, pp. 212-228.e13
Open Access | Times Cited: 181
Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells’ heterogeneity
Yehuda Schlesinger, Oshri Yosefov-Levi, Dror Kolodkin‐Gal, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 158
Epigenetic modulations and lineage plasticity in advanced prostate cancer
Rongrong Ge, Zifan Wang, Rodolfo Montironi, et al.
Annals of Oncology (2020) Vol. 31, Iss. 4, pp. 470-479
Open Access | Times Cited: 155
Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting ONECUT2
Meng Shen, Chuan Dong, Xianhui Ruan, et al.
Cancer Research (2019) Vol. 79, Iss. 14, pp. 3608-3621
Open Access | Times Cited: 152
Molecular events in neuroendocrine prostate cancer development
Yong Wang, Yu Wang, Xinpei Ci, et al.
Nature Reviews Urology (2021) Vol. 18, Iss. 10, pp. 581-596
Open Access | Times Cited: 122
Loss and revival of androgen receptor signaling in advanced prostate cancer
Nicolò Formaggio, Mark A. Rubin, Jean‐Philippe Theurillat
Oncogene (2021) Vol. 40, Iss. 7, pp. 1205-1216
Open Access | Times Cited: 104
FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer
Ming Han, Fei Li, Yehan Zhang, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1306-1323.e8
Open Access | Times Cited: 93
Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
Lina Merkens, Verena Sailer, Davor Lessel, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 86
Complexities of Prostate Cancer
Sobia Wasim, Sang‐Yoon Lee, Jaehong Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14257-14257
Open Access | Times Cited: 86
YTHDF2-mediated m6A modification of ONECUT2 promotes stemness and oxaliplatin resistance in gastric cancer through transcriptionally activating TFPI
Xingdi Fan, Fangyi Han, Haocheng Wang, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101200-101200
Closed Access | Times Cited: 2
Pioneer of prostate cancer: past, present and the future of FOXA1
Mona Teng, Stanley Zhou, Changmeng Cai, et al.
Protein & Cell (2020) Vol. 12, Iss. 1, pp. 29-38
Open Access | Times Cited: 121
Impact of Lineage Plasticity to and from a Neuroendocrine Phenotype on Progression and Response in Prostate and Lung Cancers
Mark A. Rubin, Robert G. Bristow, Phillip Thienger, et al.
Molecular Cell (2020) Vol. 80, Iss. 4, pp. 562-577
Open Access | Times Cited: 102
Neuroendocrine Differentiation of Prostate Cancer—An Intriguing Example of Tumor Evolution at Play
Girijesh Kumar Patel, Natasha Chugh, Manisha Tripathi
Cancers (2019) Vol. 11, Iss. 10, pp. 1405-1405
Open Access | Times Cited: 98
The epigenetic and transcriptional landscape of neuroendocrine prostate cancer
Alastair Davies, Amina Zoubeidi, Luke A. Selth
Endocrine Related Cancer (2019) Vol. 27, Iss. 2, pp. R35-R50
Open Access | Times Cited: 77
Cellular rewiring in lethal prostate cancer: the architect of drug resistance
Marc Cárceles-Cordon, William Kevin Kelly, Leonard G. Gomella, et al.
Nature Reviews Urology (2020) Vol. 17, Iss. 5, pp. 292-307
Open Access | Times Cited: 76
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer
Yundong He, Ting Wei, Zhenqing Ye, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 73
Therapy considerations in neuroendocrine prostate cancer: what next?
Himisha Beltran, Francesca Demichelis
Endocrine Related Cancer (2021) Vol. 28, Iss. 8, pp. T67-T78
Open Access | Times Cited: 63
Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
Marzieh Ehsani, Faith Oluwakemi David, Aria Baniahmad
Cancers (2021) Vol. 13, Iss. 7, pp. 1534-1534
Open Access | Times Cited: 61
Understanding and targeting prostate cancer cell heterogeneity and plasticity
Dean G. Tang
Seminars in Cancer Biology (2021) Vol. 82, pp. 68-93
Open Access | Times Cited: 61
Molecular mechanisms underlying the development of neuroendocrine prostate cancer
Shiqin Liu, Busola R. Alabi, Qingqing Yin, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 57-68
Open Access | Times Cited: 44
Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation
Chia-Chun Chen, Wendy Tran, Kai Song, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2066-2082.e9
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top